IVD 检测开发市场规模、占有率、预测、趋势分析：按产品（检测开发、包装开发）、按技术（免疫检测、分子诊断、生物化学）、按应用（肿瘤学、糖尿病）- 到 2031 年世界预测

预计到 2031 年，全球 IVD 检测开发市场将达到 83.9 亿美元，2024 年至 2031 年复合年增长率为 7.9%。

本报告在广泛的二级和一级研究以及对市场情景的深入分析后，对关键行业推动因素、阻碍因素、挑战和机会进行了分析。该市场的成长是由慢性病患病率上升和老年人口增加、传染病负担高、对POC IVD检测市场开发的日益关注以及医疗保健支出的增加所推动的。然而，不断变化的监管环境正在限制市场成长。

此外，新兴经济体和 IVD 检测开发中先进技术的利用预计将为该市场的参与者提供成长机会。然而，维持产品品质和保护专有资讯是影响市场成长的主要挑战。

本报告基于对主要公司的产品和区域格局以及过去几年（2021-2024 年）采取的主要成长策略的广泛评估，提供了竞争格局。全球 IVD 检测开发市场的主要公司包括 Thermo Fisher Scientific Inc.（美国）、Avioq, Inc.（美国）、Creative Biolabs, Inc.（美国）、Maxim Biomedical, Inc.（美国）、Bio-Techne Corporation （美国）、Merck KGaA（德国）、PeploBio Ltd（英国）、ICON plc（爱尔兰）、NeoDx Biotech Labs Pvt. Ltd.（印度）、Eclevar Medtech（法国）、Savyon Diagnostics（以色列）、Promega Corporation（美国）和 Future Diagnostics Solutions B.V.（荷兰）。

在本报告涵盖的产品中，IVD 稳定性测试领域预计在 2024 年至 2031 年的预测期内复合年增长率最高，将超过 8.1%。推动这种成长的是稳定性测试的好处，它有助于识别潜在的故障和效能随时间的变化。稳定性测试使公司能够检测和管理与影响体外诊断有效性的因素相关的风险，例如光照和温度变化。

在本报告涵盖的技术中，免疫分析/免疫化学领域预计将在 2024 年占据 IVD 分析开发市场的最大占有率。该行业的高市场占有率是由于免疫诊断因其固有的特定性和高通量而比其他技术更受青睐，以及先进的诊断免疫分析形式的出现。

在本报告涵盖的应用中，传染病领域预计将在 2024 年占据 IVD 检测开发市场的最大占有率。该细分市场的巨大市场占有率归因于爱滋病毒流行率的不断上升以及爱滋病毒快速诊断检测的日益普及。

对全球 IVD 检测开发市场区域状况的详细分析，提供了五个主要地区（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）的详细定性和定量见解，涵盖了主要国家。到 2024 年，北美预计将占据 IVD 检测开发市场的最大占有率，超过 37.8%。在该地区，美国预计到 2024 年将占据 IVD 检测开发市场的最大占有率。该国的高市场占有率归因于传染病流行的蔓延、政府对疾病监测和预防的稳定投资和融资以及医疗保健支出的增加。

调查范围：

IVD 检测开发市场：依产品分类

• IVD 检测开发服务
• IVD 包装开发服务
• IVD检测稳定性测试
• 监理支持
• 其他产品

（註：其他服务包括技术转移、技术支援服务以及客製化 QA 和 QC 测试）

IVD 检测开发市场：依技术划分

• 免疫测定/免疫化学
• 分子诊断
• 临床化学/生物化学
• 血液学
• 微生物学
• 尿液测试

IVD 检测开发市场：依应用划分

• 传染病
• 肿瘤学
• 糖尿病
• 循环系统
• 其他用途

（註：其他用途包括肾臟科、凝血测试、神经系统疾病）

按地区划分的 IVD 检测开发市场

• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 中东/非洲

目录

第一章简介

第二章研究方法

第 3 章执行摘要

第 4 章市场洞察

• 市场概览
• 影响市场成长的因素
  • 促进因素
    • 慢性病盛行率上升和老年人口增加
    • 传染病负担高
    • 越来越关注 POC IVD 检测开发
    • 医疗支出增加
  • 阻碍因素
    • 监理情况的变化
  • 机会
    • 新兴经济体
    • 在 IVD 检测开发中使用先进技术
  • 课题
    • 维护产品品质并保护专有讯息
  • 宏观指标
• 邻近市场分析
• IVD 检测开发市场：监管状况
  • 北美
    • 美国
    • 加拿大
  • 欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
  • 拉丁美洲
  • 中东/非洲
• 波特五力分析

第 5 章 IVD 检测开发市场评估：依产品

• 摘要
• IVD 检测开发服务
• IVD检测稳定性测试
• IVD 包装开发服务
• 监理支持
• 其他服务

第 6 章 IVD 检测开发市场：按技术

• 摘要
• 免疫测定/免疫化学
• 分子诊断
• 临床化学/生物化学
• 血液学
• 微生物学
• 尿液测试

第 7 章 IVD 检测开发市场评估：按应用

• 摘要
• 传染病
• 肿瘤学
• 糖尿病
• 循环系统
• 其他用途

第 8 章 IVD 检测开发市场评估：按地区

• 摘要
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 中东/非洲

第9章竞争分析

• 摘要
• 竞争基准测试
• 竞争对手仪表板
  • 行业领导者
  • 市场差异化因素
  • 先锋
  • 新兴公司
• 市场排名：以主要公司划分（2023 年）

第 10 章公司简介（业务概览、财务概览、产品组合、策略发展、SWOT 分析*）

• Creative Biolabs, Inc.
• Avioq, Inc.
• Thermo Fisher Scientific Inc.
• Neodx Biotech Labs Pvt. Ltd.
• Merck KGaA
• PeploBio Ltd
• Icon Plc
• Savyon Diagnostics
• Maxim Biomedical, Inc.
• Eclevar Medtech
• Promega Corporation
• Future Diagnostics Solutions B.V.

（註：提供前 5 名公司的 SWOT 分析）

第11章附录

The global IVD assay development market is projected to reach $8.39 billion by 2031 at a CAGR of 7.9% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the rising prevalence of chronic diseases & the increasing geriatric population, the high burden of infectious diseases, the growing focus on the development of POC IVD assays, and rising healthcare expenditures. However, the evolving regulatory landscape restrains the growth of this market.

Furthermore, the emerging economies and the use of advanced technologies in IVD assay development are expected to generate growth opportunities for the players operating in this market. However, maintaining product quality & protecting proprietary information are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the leading players' offerings and geographic presence and the key growth strategies adopted by them over the past few years (2021-2024). The key players operating in the global IVD assay development market are Thermo Fisher Scientific Inc. (U.S.), Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd (U.K.), ICON plc (Ireland), NeoDx Biotech Labs Pvt. Ltd. (India), Eclevar Medtech (France), Savyon Diagnostics (Israel), Promega Corporation (U.S.), and Future Diagnostics Solutions B.V. (Netherlands).

Among the offerings covered in this report, the IVD stability testing segment is projected to register the highest CAGR of over 8.1% during the forecast period of 2024-2031. This growth is driven by the benefits of stability testing, which helps identify potential breakdowns or alterations in performance over time. Stability testing enables companies to detect and manage risks related to factors that can affect the effectiveness of IVD assays, including light exposure and temperature variations.

Among the technologies covered in this report, in 2024, the immunoassay /immunochemistry segment is expected to account for the largest share of the IVD assay development market. The segment's large market share is attributed to the higher preference for immunodiagnostics compared to other technologies due to its inherent specificity and high throughput, and the emergence of advanced diagnostic immunoassay formats.

Among the applications covered in this report, in 2024, the infectious diseases segment is expected to account for the largest share of the IVD assay development market. The large market share of this segment can be attributed to the increasing prevalence of HIV and the growing availability of rapid diagnostic assays for HIV.

An in-depth analysis of the geographical scenario of the global IVD assay development market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 37.8% of the IVD assay development market. Within this region, the U.S. is expected to account for the largest share of the IVD assay development market in 2024. The country's large market share is attributed to the increasing prevalence of infectious diseases, favorable government investments and funding for disease investigation & prevention, and rising healthcare expenditure.

Scope of the Report:

IVD Assay Development Market-by Offering

• IVD Assay Development Services
• IVD Packaging Development Services
• IVD Assay Stability Testing
• Regulatory Support
• Other Offerings

(Note: Other offerings include technology transfer, technical support services, and custom QA & QC testing)

IVD Assay Development Market-by Technology

• Immunoassay/Immunochemistry
• Molecular Diagnostics
• Clinical Chemistry/Biochemistry
• Hematology
• Microbiology
• Urinalysis

IVD Assay Development Market-by Application

• Infectious Diseases
• Oncology
• Diabetes
• Cardiology
• Other Applications

(Note: Other applications include nephrology, coagulation tests, and neurological disorders.)

IVD Assay Development Market-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Drivers
    • 4.2.1.1. Rising Prevalence of Chronic Diseases & the Increasing Geriatric Population
    • 4.2.1.2. High Burden of Infectious Diseases
    • 4.2.1.3. Growing Focus on the Development of POC IVD Assays
    • 4.2.1.4. Rising Healthcare Expenditures
  • 4.2.2. Restraints
    • 4.2.2.1. Evolving Regulatory Landscape
  • 4.2.3. Opportunities
    • 4.2.3.1. Emerging Economies
    • 4.2.3.2. Use of Advanced Technologies in IVD Assay Development
  • 4.2.4. Challenges
    • 4.2.4.1. Maintaining Product Quality & Protecting Proprietary Information
  • 4.2.5. Macro Indicators
• 4.3. Adjacent Market Analysis
• 4.4. IVD Assay Development Market: Regulatory Landscape
  • 4.4.1. North America
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada
  • 4.4.2. Europe
  • 4.4.3. Asia-Pacific
    • 4.4.3.1. Japan
    • 4.4.3.2. China
    • 4.4.3.3. India
  • 4.4.4. Latin America
  • 4.4.5. Middle East & Africa
• 4.5. Porter's Five Forces Analysis
  • 4.5.1. Bargaining Power of Suppliers
  • 4.5.2. Bargaining Power of Buyers
  • 4.5.3. Threat of Substitutes
  • 4.5.4. Threat of New Entrants
  • 4.5.5. Degree of Competition

5. IVD Assay Development Market Assessment-by Offering

• 5.1. Overview
• 5.2. IVD Assay Development Services
• 5.3. IVD Assay Stability Testing
• 5.4. IVD Packaging Development Services
• 5.5. Regulatory Support
• 5.6. Other offerings

6. IVD Assay Development Market-by Technology

• 6.1. Overview
• 6.2. Immunoassay/Immunochemistry
• 6.3. Molecular Diagnostics
• 6.4. Clinical Chemistry/Biochemistry
• 6.5. Hematology
• 6.6. Microbiology
• 6.7. Urinalysis

7. IVD Assay Development Market Assessment-by Application

• 7.1. Overview
• 7.2. Infectious Diseases
• 7.3. Oncology
• 7.4. Diabetes
• 7.5. Cardiology
• 7.6. Other Applications

8. IVD Assay Development Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. U.K.
  • 8.3.3. France
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. South Korea
  • 8.4.6. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Competitive Benchmarking
• 9.3. Competitive Dashboard
  • 9.3.1. Industry Leaders
  • 9.3.2. Market Differentiators
  • 9.3.3. Vanguards
  • 9.3.4. Emerging Companies
• 9.4. Market Ranking, by Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, And SWOT Analysis*)

• 10.1. Creative Biolabs, Inc.
• 10.2. Avioq, Inc.
• 10.4. Thermo Fisher Scientific Inc.
• 10.5. Neodx Biotech Labs Pvt. Ltd.
• 10.6. Merck KGaA
• 10.7. PeploBio Ltd
• 10.8. Icon Plc
• 10.9. Savyon Diagnostics
• 10.10. Maxim Biomedical, Inc.
• 10.11. Eclevar Medtech
• 10.12. Promega Corporation
• 10.13. Future Diagnostics Solutions B.V.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports

LIST OF TABLES

• Table 1 Healthcare Expenditure per Capita, by Country, 2021/2022 (USD)
• Table 2 Global Human Immunodeficiency Virus (HIV) Statistics, 2023
• Table 3 Percentage of the Population Aged 65 Years or over, by Region, 2022 VS. 2030 VS. 2050
• Table 4 Global IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 5 Global IVD Assay Development Services Market, by Country/Region, 2022-2031 (USD Million)
• Table 6 Global IVD Assay Stability Testing Market, by Country/Region, 2022-2031 (USD Million)
• Table 7 Global IVD Packaging Development Services Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global IVD Assay Development Regulatory Support Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Other IVD Assay Development Offerings Market, by Country/Region, 2022-2031 (USD Million)
• Table 10 Global IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 11 Global IVD Assay Development Market for Immunoassay/ Immunochemistry, by Country/Region, 2022-2031 (USD Million)
• Table 12 Global IVD Assay Development Market for Molecular Diagnostics, by Country/Region, 2022-2031 (USD Million)
• Table 13 Global IVD Assay Development Market for Clinical Chemistry/Biochemistry, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global IVD Assay Development Market for Hematology, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global IVD Assay Development Market for Microbiology, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global IVD Assay Development Market for Urinalysis, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 18 Global IVD Assay Development Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global IVD Assay Development Market for Oncology, by Country/Region, 2022-2031 (USD Million)
• Table 20 Number of People with Diabetes Aged 20-79 Years, BY Region, 2021 VS. 2030 VS. 2045 (In Million)
• Table 21 Global IVD Assay Development Market for Diabetes, by Country/Region, 2022-2031 (USD Million)
• Table 22 Global IVD Assay Development Market for Cardiology, by Country/Region, 2022-2031 (USD Million)
• Table 23 Global IVD Assay Development Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 24 Global IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 25 North America: IVD Assay Development Market, by Country, 2022-2031 (USD Million)
• Table 26 North America: IVD Assay Development Market, BY offering, 2022-2031 (USD Million)
• Table 27 North America: IVD Assay Development Market, BY Technology, 2022-2031 (USD Million)
• Table 28 North America: IVD Assay Development Market, BY Application, 2022-2031 (USD Million)
• Table 29 U.S.: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 30 U.S.: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 31 U.S.: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 32 Canada: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 33 Canada: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 34 Canada: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 35 Europe: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 36 Europe: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 37 Europe: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 38 Europe: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 39 Germany: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 40 Germany: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 41 Germany: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 42 Number of Incidents of Influenza and Other Respiratory Diseases in England, by Institution and Virus Type, Winter 2022 To 2023
• Table 43 U.K.: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 44 U.K.: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 45 U.K.: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 46 France: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 47 France: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 48 France: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 49 Italy: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 50 Italy: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 51 Italy: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 52 Spain: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 53 Spain: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 54 Spain: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 55 Roe: Estimated Number of New Cancer Cases, by Country (2022 Vs. 2030)
• Table 56 Rest of Europe: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 57 Rest of Europe: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 58 Rest of Europe: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 59 Asia-Pacific: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 60 Asia-Pacific: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 61 Asia-Pacific: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 62 Asia-Pacific: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 63 China: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 64 China: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 65 China: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 66 Japan: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 67 Japan: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 68 Japan: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 69 India: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 70 India: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 71 India: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 72 Australia: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 73 Australia: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 74 Australia: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 75 South Korea: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 76 South Korea: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 77 South Korea: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 78 Rest of Asia-Pacific: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 79 Rest of Asia-Pacific: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 80 Rest of Asia-Pacific: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 81 Latin America: IVD Assay Development Market, by Country/Region, 2022-2031 (USD Million)
• Table 82 Latin America: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 83 Latin America: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 84 Latin America: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 85 Brazil: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 86 Brazil: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 87 Brazil: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 88 Mexico: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 89 Mexico: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 90 Mexico: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 91 Rest of Latin America: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 92 Rest of Latin America: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 93 Rest of Latin America: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 94 Middle East & Africa: IVD Assay Development Market, by Offering, 2022-2031 (USD Million)
• Table 95 Middle East & Africa: IVD Assay Development Market, by Technology, 2022-2031 (USD Million)
• Table 96 Middle East & Africa: IVD Assay Development Market, by Application, 2022-2031 (USD Million)
• Table 97 Global IVD Assay Development Market Rankings, by Key Players, 2023

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Secondary Sources Referenced for This Study
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
• Figure 6 Market Sizing and Growth Forecast Approach
• Figure 7 Global IVD Assay Development Market, by offering, 2024 Vs.2031 (USD Million)
• Figure 8 Global IVD Assay Development Market, by Technology, 2024 Vs. 2031 (USD Million)
• Figure 9 Global IVD Assay Development Market, by Application, 2024 Vs. 2031 (USD MILLION)
• Figure 10 Global IVD Assay Development Market, by Geography, 2024 VS 2031 (USD Million)
• Figure 11 Impact Analysis of Market Dynamics
• Figure 12 GLOBAL Biopharmaceutical R&D Expenditure, 2016-2026 (USD Billion)
• Figure 13 Estimated Number of New Cancer Cases, by Region, 2022 VS. 2030
• Figure 14 Number of People with Diabetes Aged 20-79 Years, by Region, 2021 VS. 2030 VS. 2045 (in Million)
• Figure 15 IVD Market Share, BY Technology, 2024
• Figure 16 IVD Reagents Market, by Type, 2024 Vs. 2031 (USD Million)
• Figure 17 IVD Contract Manufacturing Services Market, by Type, 2024 Vs. 2031 (USD Million)
• Figure 18 Porter's Five Forces Analysis
• Figure 19 Global IVD Assay Development Market, by offering, 2024 VS. 2031 (USD Million)
• Figure 20 IVD Assay Development Phases
• Figure 21 Global IVD Assay Development Market, by Technology, 2024 VS. 2031 (USD Million)
• Figure 22 Global IVD Assay Development Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 23 Estimated Number of New Cancer Cases, by Region, 2022-2030
• Figure 24 Global IVD Assay Development Market, by Country/Region, 2024 Vs. 2031 (USD Million)
• Figure 25 North America: IVD Assay Development Market Snapshot
• Figure 26 Europe: IVD Assay Development Market Snapshot
• Figure 27 France: Percentage of the Population Aged 65 Years and Above (2016-2020)
• Figure 28 Number of HIV Tests Performed in Catalonia (Spain), 2014-2021
• Figure 29 Asia-Pacific: IVD Assay Development Market Snapshot
• Figure 30 China: Independent Medical Laboratories Market Size (USD Million)
• Figure 31 Japan: Percentage of Aging Population (65 Years and Above), 2016-2050
• Figure 32 Latin America: IVD Assay Development Market Snapshot
• Figure 33 IVD Assay Development Market: Competitive Benchmarking (Based on Offering)
• Figure 34 IVD Assay Development Market: Competitive Benchmarking (Based on Geography)
• Figure 35 Competitive Dashboard: IVD Assay Development Market
• Figure 36 Bio-Techne Corporation: Financial Snapshot (2023)
• Figure 37 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
• Figure 38 Merck KGaA: Financial Snapshot (2023)
• Figure 39 ICON Plc: Financial Snapshot (2023)